Treatment for Livedoid Vasculopathy: A Systematic... (2018 study) Skip to main content
Systematic Review JAMA Dermatol 2018 Canadian

Treatment for Livedoid Vasculopathy: A Systematic Review

Micieli R, Alavi A, JAMA Dermatol, 2018

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers searched two medical databases for published case series on treatments for livedoid vasculopathy, a painful ulcer-forming condition of the lower legs, and combined what they found.

What They Found

This systematic review of 29 case series covering 339 patients found that many different treatments, including hyperbaric oxygen, were reported to have a favorable outcome, with anticoagulants the most commonly used single therapy at 62 of 63 patients (98%) with a favorable response. Of the 339 patients, 230 (68%) were female and 69 (20%) were male, and sex was not stated for 40. The other treatments listed were antiplatelets, anabolic steroids, thrombolytics, intravenous immunoglobulins, vitamin supplementation and UV light, and combinations of these. Adverse events were seen in 44 patients (13%).

What This Means for Canadian Patients

The abstract lists hyperbaric oxygen as one of several treatments with a favorable outcome in these case series, but it gives no results, pressures or session counts for hyperbaric oxygen on its own. The authors say no established treatment exists for livedoid vasculopathy and that the evidence comes mainly from case reports and case series. Patients with this condition should talk with their physician about the options.

Canadian Relevance

The study or its authors have a Canadian connection.

Study Limitations

The review is based only on case reports and case series, which are low levels of evidence, so it cannot show that any one treatment works better than another, and the authors say randomized clinical trials are still needed.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Wound Care
Source Pubmed
PubMed ID 29141075
Year Published 2018
Journal JAMA Dermatol
MeSH Terms Adrenal Cortex Hormones; Anticoagulants; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Immunoglobulins, Intravenous; Livedo Reticularis; Male; PUVA Therapy; Prognosis; Risk Assessment; Severity of Illness Index; Skin Diseases, Vascular; Treatment Outcome

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology